Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 183 citing Bonora: HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease.... (0.81 sec) 

Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in …


HE Resnick, K Jones, G Ruotolo, AK Jain, J … - Diabetes Care, 2003 - Am Diabetes Assoc
RESULTS—MS was present in 798 individuals (35%), and 181 participants (7.9%)
developed CVD over 7.6 ± 1.8 years of follow-up. Age, BMI, waist circumference,
and triglyceride levels increased and HDL cholesterol decreased across ...
Cited by 243 - Related articles - BL Direct - All 5 versions

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic …


M Romero-Gómez, M Del Mar Viloria, RJ … - Gastroenterology, 2005 - Elsevier
Background & Aims: We evaluated the effect of insulin resistance and viral
factors on sustained virological response in patients with chronic hepatitis C
treated with peginterferon plus ribavirin. Methods: Patients (n = 159; 94 ...
Cited by 211 - Related articles - All 10 versions

The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 …


E Bonora, G Targher, G Formentini, F … - Diabetic Medicine, 2004 - interscience.wiley.com
Methods Subjects with the Metabolic Syndrome, defined by WHO criteria, were
identified in a large sample of non-insulin-treated Type 2 diabetic patients
examined within the Verona Diabetes Complications Study (n = 946). At ...
Cited by 159 - Related articles - BL Direct - All 4 versions

Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high- …

- endojournals.org
B Hansel, P Giral, E Nobecourt, S Chantepie … - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc
MetS subjects presented an insulin-resistant phenotype, with central obesity and
elevation in systolic blood pressure and plasma triglyceride, LDL-cholesterol,
apolipoprotein B, glucose, and insulin levels. Systemic oxidative stress, ...
Cited by 124 - Related articles - BL Direct - All 4 versions

Plasma adiponectin levels are associated with insulin resistance, but do not predict future …

- endojournals.org
DA Lawlor, D Smith… - Journal of Clinical Endocrinology & Metabolism, 2005 - Endocrine Soc
Context: Low adiponectin levels predict type 2 diabetes, and one prospective
study in men reported its independent prediction of vascular events. Many
observers thus already consider adiponectin to be a major part of the ...
Cited by 114 - Related articles - BL Direct - All 6 versions

Population-based incidence rates and risk factors for type 2 diabetes in white individuals


E Bonora, S Kiechl, J Willeit, F … - Diabetes, 2004 - Am Diabetes Assoc
Incidence rates and risk factors for type 2 diabetes in low-risk populations are
not well documented. We investigated these in white individuals who were aged
40–79 years and from the population of Bruneck, Italy. Of an age- and sex- ...
Cited by 96 - Related articles - BL Direct - All 4 versions

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular …


G Targher, L Bertolini, R Padovani, S Rodella, … - Diabetes Care, 2007 - Am Diabetes Assoc
RESULTS—The unadjusted prevalence of NAFLD was 69.5% among participants, and
NAFLD was the most common cause (81.5%) of hepatic steatosis on ultrasound
examination. The prevalence of NAFLD increased with age (65.4% among ...
Cited by 79 - Related articles - BL Direct - All 8 versions

Peroxisome proliferator-activated receptor-γ: therapeutic target for diseases beyond …


HA Pershadsingh - eid, 2004 - informahealthcare.com
The discovery that the insulin-sensitising thiazolidinediones (TZDs), specific
peroxisome proliferator-activated receptor-γ (PPARγ) agonists, have antipro-
liferative, anti-inflammatory and immunomodulatory effects has led to the ...
Cited by 68 - Related articles - All 5 versions

Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 …


PA Sarafidis, AN Lasaridis, PM Nilsson, EM … - Journal of Hypertension, 2004 - journals.lww.com
Page 1. Ambulatory blood pressure reduction after rosiglitazone treatment
in patients with type 2 diabetes and hypertension correlates ...
Cited by 67 - Related articles - BL Direct - All 5 versions

Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in …


T Tsunekawa, T Hayashi, Y Suzuki, H Matsui- … - Diabetes care, 2003 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—A total of 17 elderly patients with type 2
diabetes received 12 weeks of treatment with glimepiride. Homeostasis assessment
model of insulin resistance (HOMA-IR), homeostasis assessment model of ...
Cited by 68 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google